Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan Yue

Showing results (141-150 of 149) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 149 results.
Cell Reports|October 17, 2025
STBD1 mediates the crosstalk between glycogen and lipid droplets in clear cell renal cell carcinomaHao Wang, Tong Xiao, Hao Zhuang, et al.
Journal of Korean Medical Science|March 1, 2017
Characteristics and Impact Factors of Renal Threshold for Glucose Excretion in Patients with Type 2 Diabetes MellitusXiao Dan Yue, Jing Yu Wang, Xin Rong Zhang, et al.
Journal of Diabetes and Its Complications|May 11, 2015
Renal tubular damage may contribute more to acute hyperglycemia induced kidney injury in non-diabetic conscious ratsJing-Yu Wang, Ju-Hong Yang, Jie Xu, et al.
Frontiers in Immunology|September 10, 2024
Decitabine-based treatment strategy improved the outcome of HSCT in JMML: a retrospective cohort studyZhiyong Peng, Jingyu Gao, Litao Huang, et al.
Cancer|October 12, 2013
Prognostic value of chronic hepatitis B virus infection in patients with nasopharyngeal carcinoma: analysis of 1301 patients from an endemic area in ChinaXu Liu, Xing Li, Ning Jiang, et al.
Science Advances|May 20, 2020
Crystal structure of bovine herpesvirus 1 glycoprotein D bound to nectin-1 reveals the basis for its low-affinity binding to the receptorDan Yue, Zhujun Chen, Fanli Yang, et al.
Cell Host & Microbe|February 1, 2020
Structural Analysis of Rabies Virus Glycoprotein Reveals pH-Dependent Conformational Changes and Interactions with a Neutralizing AntibodyFanli Yang, Sheng Lin, Fei Ye, et al.
Lancet (London, England)|June 10, 2021
Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trialYu-Pei Chen, Xu Liu, Qin Zhou, et al.
Nature Cancer|July 1, 2026
Long-term outcomes of adjuvant metronomic capecitabine in locoregionally advanced nasopharyngeal carcinoma: a randomized, controlled, multicenter, phase 3 studyYa-Lan Tao, Dong-Hong Wu, Qin Zhou, et al.
Pageof 15

Showing results (141-150 of 149) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 149 results.
Cell Reports|October 17, 2025
STBD1 mediates the crosstalk between glycogen and lipid droplets in clear cell renal cell carcinomaHao Wang, Tong Xiao, Hao Zhuang, et al.
Journal of Korean Medical Science|March 1, 2017
Characteristics and Impact Factors of Renal Threshold for Glucose Excretion in Patients with Type 2 Diabetes MellitusXiao Dan Yue, Jing Yu Wang, Xin Rong Zhang, et al.
Journal of Diabetes and Its Complications|May 11, 2015
Renal tubular damage may contribute more to acute hyperglycemia induced kidney injury in non-diabetic conscious ratsJing-Yu Wang, Ju-Hong Yang, Jie Xu, et al.
Frontiers in Immunology|September 10, 2024
Decitabine-based treatment strategy improved the outcome of HSCT in JMML: a retrospective cohort studyZhiyong Peng, Jingyu Gao, Litao Huang, et al.
Cancer|October 12, 2013
Prognostic value of chronic hepatitis B virus infection in patients with nasopharyngeal carcinoma: analysis of 1301 patients from an endemic area in ChinaXu Liu, Xing Li, Ning Jiang, et al.
Science Advances|May 20, 2020
Crystal structure of bovine herpesvirus 1 glycoprotein D bound to nectin-1 reveals the basis for its low-affinity binding to the receptorDan Yue, Zhujun Chen, Fanli Yang, et al.
Cell Host & Microbe|February 1, 2020
Structural Analysis of Rabies Virus Glycoprotein Reveals pH-Dependent Conformational Changes and Interactions with a Neutralizing AntibodyFanli Yang, Sheng Lin, Fei Ye, et al.
Lancet (London, England)|June 10, 2021
Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trialYu-Pei Chen, Xu Liu, Qin Zhou, et al.
Nature Cancer|July 1, 2026
Long-term outcomes of adjuvant metronomic capecitabine in locoregionally advanced nasopharyngeal carcinoma: a randomized, controlled, multicenter, phase 3 studyYa-Lan Tao, Dong-Hong Wu, Qin Zhou, et al.
Pageof 15